Synlogic News - Sybx), a biopharmaceutical company advancing.
Synlogic (SYBX) Presents At 24th Annual NewsMakers in the Biotech
Sybx), a biopharmaceutical company advancing.
Synlogic advancing novel biotherapeutics based on synthetic biology
Sybx), a biopharmaceutical company advancing.
Synlogic preps phenylketonuria drug for phase 3 after midstage win
Sybx), a biopharmaceutical company advancing.
Synlogic Bridging Study Data with Solid Oral Formulation of SYNB1618, a
Sybx), a biopharmaceutical company advancing.
Synlogic Stock SYNB1934 Advances To Phase 3 (NASDAQSYBX) Seeking Alpha
Sybx), a biopharmaceutical company advancing.
Synlogic A ClinicalStage Biopharma With A Good Risk/Reward Ratio
Sybx), a biopharmaceutical company advancing.
Synlogic (SYBX) Presents At 24th Annual NewsMakers in the Biotech
Sybx), a biopharmaceutical company advancing.
Synlogic (SYBX) Presents At 24th Annual NewsMakers in the Biotech
Sybx), a biopharmaceutical company advancing.
Synlogic Announces Fourth Quarter and Full Year 2019 Conference Call
Sybx), a biopharmaceutical company advancing.
Synlogic PrecisionProgrammed Probiotics To Treat Human Disease
Sybx), a biopharmaceutical company advancing.
Sybx), a biopharmaceutical company advancing.